Literature DB >> 4889358

Immunosuppressive therapy of ocular inflammatory diseases.

V G Wong.   

Abstract

Mesh:

Substances:

Year:  1969        PMID: 4889358     DOI: 10.1001/archopht.1969.00990010630006

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


× No keyword cloud information.
  9 in total

Review 1.  Immunosuppression in uveitis therapy.

Authors:  R N Van Gelder; H J Kaplan
Journal:  Springer Semin Immunopathol       Date:  1999

2.  Behçet's disease and the alimentary tract.

Authors:  J V Parkin; D G Wight
Journal:  Postgrad Med J       Date:  1975-04       Impact factor: 2.401

3.  Treatment of Behcet's disease with chlorambucil.

Authors:  D Tricoulis
Journal:  Br J Ophthalmol       Date:  1976-01       Impact factor: 4.638

4.  Chronic cyclitis: corticosteroid therapy.

Authors:  W A Godfrey; R E Smith; S J Kimura
Journal:  Trans Am Ophthalmol Soc       Date:  1976

5.  Long-lasting remission of Behcet's disease after chlorambucil therapy.

Authors:  M I Abdalla; N el-D Bahoat
Journal:  Br J Ophthalmol       Date:  1973-09       Impact factor: 4.638

6.  Behçet's syndrome: treatment with chlorambucil.

Authors:  J H Elliott; W H Ballinger
Journal:  Trans Am Ophthalmol Soc       Date:  1984

7.  The colitis of Behcet's disease: a separate entity? Colonoscopic findings and literature review.

Authors:  G E Smith; L R Kime; J L Pitcher
Journal:  Am J Dig Dis       Date:  1973-11

8.  Cyclophosphamide and whole organ transplantation in human beings.

Authors:  T E Starzl; C W Putnam; C G Halgrimson; G T Schroter; G Martineau; B Launois; J L Corman; I Penn; A S Booth; C G Groth; K A Porter
Journal:  Surg Gynecol Obstet       Date:  1971-12

9.  Methotrexate for ocular inflammatory diseases.

Authors:  Sapna Gangaputra; Craig W Newcomb; Teresa L Liesegang; R Oktay Kaçmaz; Douglas A Jabs; Grace A Levy-Clarke; Robert B Nussenblatt; James T Rosenbaum; Eric B Suhler; Jennifer E Thorne; C Stephen Foster; John H Kempen
Journal:  Ophthalmology       Date:  2009-09-12       Impact factor: 12.079

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.